Last updated: September 6, 2021
Sponsor: The University of Hong Kong
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteosarcoma
Treatment
N/AClinical Study ID
NCT03298971
UW 17-331
Ages < 30 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Hong Kong Chinese under the age of 30 years at the time of study participation;
- Diagnosed with osteosarcoma under the age of 19 years;
- Completed the entire course of treatment at least 5 years;
- Able to speak fluent Cantonese and read Chinese.
Exclusion
Exclusion Criteria:
- Survivors with secondary malignancy, organic cause psychosis, cognitive or learningproblems, or under active cancer treatment
Study Design
Total Participants: 240
Study Start date:
September 08, 2017
Estimated Completion Date:
December 01, 2022
Study Description
Connect with a study center
The University of Hong Kong
Hong Kong,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.